Approval for broader use of DDI.
D016049:Didanosine / Q000627:therapeutic use*; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine; D016049:Didanosine